These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37565402)

  • 1. Reply to Letter to the Editor: "Disease Progression in Multiple System Atrophy: The Value of Clinical Cohorts with Long Follow-Up".
    Raket LL; Hansen IH; Kühnel L; Åström DO; Berger AK; Krismer F; Wenning GK; Seppi K; Poewe W; Molinuevo JL
    Mov Disord; 2023 Aug; 38(8):1569-1570. PubMed ID: 37565402
    [No Abstract]   [Full Text] [Related]  

  • 2. Disease Progression in Multiple System Atrophy: The Value of Clinical Cohorts with Long Follow-Up.
    Saulnier T; Fabbri M; Pavy-Le Traon A; Le Goff M; Helmer C; Péran P; Meissner WG; Rascol O; Foubert-Samier A; Proust-Lima C
    Mov Disord; 2023 Aug; 38(8):1567-1569. PubMed ID: 37565400
    [No Abstract]   [Full Text] [Related]  

  • 3. Reply to the Letter to the Editor of Tomoyuki Kawada concerning "Self-reported urinary impairment identifies 'fast progressors' in terms of neuronal loss in multiple system atrophy".
    Guevara C
    Auton Neurosci; 2019 Sep; 220():102561. PubMed ID: 31231015
    [No Abstract]   [Full Text] [Related]  

  • 4. Progression of striatal and extrastriatal degeneration in multiple system atrophy: a longitudinal diffusion-weighted MR study.
    Pellecchia MT; Barone P; Vicidomini C; Mollica C; Salvatore E; Ianniciello M; Liuzzi R; Longo K; Picillo M; De Michele G; Filla A; Brunetti A; Salvatore M; Pappatà S
    Mov Disord; 2011 Jun; 26(7):1303-9. PubMed ID: 21469200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reply to letter: Multiple system atrophy-parkinsonism with slow progression and prolonged survival: a diagnostic catch.
    Ling H; Petrovic IN; Lang AE; Lees AJ
    Mov Disord; 2013 Mar; 28(3):408. PubMed ID: 23389844
    [No Abstract]   [Full Text] [Related]  

  • 6. Progression of subcortical atrophy and iron deposition in multiple system atrophy: a comparison between clinical subtypes.
    Lee JH; Kim TH; Mun CW; Kim TH; Han YH
    J Neurol; 2015 Aug; 262(8):1876-82. PubMed ID: 26016683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral atrophy in multiple system atrophy by MRI.
    Horimoto Y; Aiba I; Yasuda T; Ohkawa Y; Katayama T; Yokokawa Y; Goto A; Ito Y
    J Neurol Sci; 2000 Feb; 173(2):109-12. PubMed ID: 10675653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormalities on structural MRI associate with faster disease progression in multiple system atrophy.
    Krismer F; Seppi K; Wenning GK; Papapetropoulos S; Abler V; Goebel G; Schocke M; Poewe W
    Parkinsonism Relat Disord; 2019 Jan; 58():23-27. PubMed ID: 30145124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurofilament light levels predict clinical progression and death in multiple system atrophy.
    Chelban V; Nikram E; Perez-Soriano A; Wilke C; Foubert-Samier A; Vijiaratnam N; Guo T; Jabbari E; Olufodun S; Gonzalez M; Senkevich K; Laurens B; Péran P; Rascol O; Le Traon AP; Todd EG; Costantini AA; Alikhwan S; Tariq A; Ng BL; Muñoz E; Painous C; Compta Y; Junque C; Segura B; Zhelcheska K; Wellington H; Schöls L; Jaunmuktane Z; Kobylecki C; Church A; Hu MTM; Rowe JB; Leigh PN; Massey L; Burn DJ; Pavese N; Foltynie T; Pchelina S; Wood N; Heslegrave AJ; Zetterberg H; Bocchetta M; Rohrer JD; Marti MJ; Synofzik M; Morris HR; Meissner WG; Houlden H
    Brain; 2022 Dec; 145(12):4398-4408. PubMed ID: 35903017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural history of multiple system atrophy in the USA: a prospective cohort study.
    Low PA; Reich SG; Jankovic J; Shults CW; Stern MB; Novak P; Tanner CM; Gilman S; Marshall FJ; Wooten F; Racette B; Chelimsky T; Singer W; Sletten DM; Sandroni P; Mandrekar J
    Lancet Neurol; 2015 Jul; 14(7):710-9. PubMed ID: 26025783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visualization and quantification of disease progression in multiple system atrophy.
    Hauser TK; Luft A; Skalej M; Nägele T; Kircher TT; Leube DT; Schulz JB
    Mov Disord; 2006 Oct; 21(10):1674-81. PubMed ID: 16830312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in the blood-brain barrier status closely correlate with the rate of disease progression in patients with multiple system atrophy: a longitudinal study.
    Lee JE; Song SK; Hong JY; Sunwoo MK; Park HJ; Sohn YH; Lee PH
    Parkinsonism Relat Disord; 2013 Apr; 19(4):450-2. PubMed ID: 23298807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive cerebral atrophy in multiple system atrophy.
    Konagaya M; Konagaya Y; Sakai M; Matsuoka Y; Hashizume Y
    J Neurol Sci; 2002 Mar; 195(2):123-7. PubMed ID: 11897242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delineating the sites and progression of in vivo atrophy in multiple system atrophy using fluid-registered MRI.
    Schott JM; Simon JE; Fox NC; King AP; Khan MN; Cipolotti L; Paviour DC; Stevens JM; Rossor MN
    Mov Disord; 2003 Aug; 18(8):955-8. PubMed ID: 12889090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression of brain atrophy in multiple system atrophy. A longitudinal VBM study.
    Brenneis C; Egger K; Scherfler C; Seppi K; Schocke M; Poewe W; Wenning GK
    J Neurol; 2007 Feb; 254(2):191-6. PubMed ID: 17334661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurodegenerative disease: Multiple system atrophy-new insight from prospective studies.
    Poewe W; Krismer F
    Nat Rev Neurol; 2015 Aug; 11(8):430-1. PubMed ID: 26195260
    [No Abstract]   [Full Text] [Related]  

  • 17. Factors associated with deterioration of health-related quality of life in multiple system atrophy: 1-year follow-up study.
    Jecmenica-Lukic MV; Pekmezovic TD; Petrovic IN; Dragasevic NT; Kostić VS
    Acta Neurol Belg; 2018 Dec; 118(4):589-595. PubMed ID: 29949032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression of dysautonomia in multiple system atrophy: a prospective study of self-perceived impairment.
    Köllensperger M; Stampfer-Kountchev M; Seppi K; Geser F; Frick C; Del Sorbo F; Albanese A; Gurevich T; Giladi N; Djaldetti R; Schrag A; Low PA; Mathias CJ; Poewe W; Wenning GK
    Eur J Neurol; 2007 Jan; 14(1):66-72. PubMed ID: 17222116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of Conversion to α-Synucleinopathy Diseases in Idiopathic Rapid Eye Movement Sleep Behavior Disorder.
    Ye G; Li Y; Zhou L; Zhang Y; Zhu L; Zhao A; Kang W; Liu J
    J Parkinsons Dis; 2020; 10(4):1443-1455. PubMed ID: 32986685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurofilament Light Chain Predicts Disease Severity and Progression in Multiple System Atrophy.
    Zhang L; Cao B; Hou Y; Gu X; Wei Q; Ou R; Zhao B; Luo C; Shang H
    Mov Disord; 2022 Feb; 37(2):421-426. PubMed ID: 34719813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.